Recombinant CD3E (Otelixizumab Biosimilar) 抗体
This Humanized Chimeric antibody specifically detects CD3E (Otelixizumab Biosimilar) in ELISA 和 WB. It exhibits reactivity toward 人.
产品编号 ABIN7538054
发货至:
中国
Contact our Customer Service for availability and price in your country.
Contact Info
Our Local Distributor
中国
北京 101111
北京 101111
No. 88 KeChuang 6th Street
Beijing Economic Technological Development Area
Room 801-803
Quick Overview for Recombinant CD3E (Otelixizumab Biosimilar) 抗体 (ABIN7538054)
抗原
CD3E (Otelixizumab Biosimilar)
抗体类型
Recombinant Antibody
适用
人
宿主
Humanized
克隆类型
Chimeric
标记
This CD3E (Otelixizumab Biosimilar) antibody is un-conjugated
应用范围
ELISA, Western Blotting (WB)
质量等级
Research Grade
-
-
Expression System
- Mammalian cells
-
原理
- Otelixizumab Biosimilar - Anti-CD3E mAb - Research Grade
-
产品特性
- Antibody Type: IgG1-lambda
-
纯化方法
- Recombinant antibody expressed in mammalien cells and purified.
-
纯度
- > 85%
-
亚型
- IgG1 lambda
-
-
-
-
限制
- 仅限研究用
-
-
-
缓冲液
- PBS buffer PH7.5
-
储存条件
- -80 °C
-
储存方法
- store at -80°C
-
-
- CD3E (Otelixizumab Biosimilar)
-
物质类
- Biosimilar
-
背景
- Otelixizumab is a recombinant Humanized (from rat) antibody to Human CD3E. Otelixizumab, also known as TRX4, is a monoclonal antibody, which is being developed for the treatment of type 1 diabetes and other autoimmune diseases.
-
CAS-编号
- 881191-44-2
抗原
-
You are here:
